A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

Clinical trial NCT06883539 · RECRUITING

Trial details

NCT number: NCT06883539
Sponsor: LaunXP Biomedical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Malignancies, Cancer Solid Cancers Solid Tumor Cancer Solid Tumor, Unspecified, Adult Solid Tumour Solid Tumors Refractory to Standard Therapy HCC - Hepatocellular Carcinoma RCC, Renal Cell Cancer Pancreas Cancer

Start date: 2024-12-31
Primary completion: 2027-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.